TECX — Tectonic Therapeutic Cashflow Statement
0.000.00%
Last trade - 00:00- $406.01m
- $265.64m
- 34
- 23
- 37
- 22
Annual cashflow statement for Tectonic Therapeutic, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -8.93 | -32.2 | -42.8 | -58 |
| Depreciation | ||||
| Non-Cash Items | -5.81 | 1.7 | 1.25 | 7.54 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 1.92 | 1.84 | -0.584 | -10.3 |
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -12.5 | -27.6 | -40.7 | -59.1 |
| Capital Expenditures | -2.12 | -2.09 | -0.279 | -0.156 |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | -2.12 | -2.09 | -0.279 | -0.156 |
| Financing Cash Flow Items | — | 0 | 34.1 | 76 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 41.4 | 37.6 | 33.7 | 172 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 26.8 | 7.9 | -7.2 | 112 |